Yakira Capital Management Calls on Atrium Therapeutics to Launch Strategic Review, Curb Cash Spending and Explain Dilutive Financing
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq futures drop over 1% as AI worries resurface, oil climbs
- Oil jumps on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
| PROSENSA HOLD (NASDAQ: RNA) | Delayed: 8.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.00 | 52 Week High | $22.80 | |||
| Open | $8.00 | 52 Week Low | $4.12 | |||
| Day High | $8.00 | P/E | N/A | |||
| Day Low | $8.00 | EPS | $0.00 | |||
| Volume | 1,250 | |||||
| PROSENSA HOLD (NASDAQ: RNA) | Delayed: 8.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.00 | 52 Week High | $22.80 | |||
| Open | $8.00 | 52 Week Low | $4.12 | |||
| Day High | $8.00 | P/E | N/A | |||
| Day Low | $8.00 | EPS | $0.00 | |||
| Volume | 1,250 | |||||
